• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

UCB

revolving door office
Pharma

JPM26, Day 2: Novo CEO talks 'mastering' cash pay sales in '26

Today will feature presentations from Big Pharmas including GSK, AstraZeneca and Novo Nordisk, and Fierce's own event kicks off at the Hyatt Regency.
Angus Liu , Zoey Becker , Fraiser Kansteiner , Kevin Dunleavy , Eric Sagonowsky Jan 13, 2026 7:29pm
UCB sign

Results for UCB's Fintepla pave way for 3rd epileptic indication

Dec 8, 2025 11:19am
Rising Stars in Pharma Marketing QA series header image

Rising Stars: How Katie Swicegood Fulp made the leap to pharma

Nov 5, 2025 6:00am
UCB sign

Fast-rising UCB scores FDA nod for rare disease drug Kygevvi

Nov 4, 2025 11:36am
Imaavy

J&J's Imaavy comes up short in rheumatoid arthritis study

Aug 29, 2025 10:56am
Argenx

Argenx pursues Vyvgart nod in seronegative myasthenia gravis

Aug 25, 2025 11:38am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings